Clinical Trial Update: A Study of SRSD216 in Patients With Elevated Lipoprotein (a) [Phase 1, Phase 2]

View source ↗

Summary

This document notes a Phase 1/2 clinical trial of SRSD216 for elevated lipoprotein (a), currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipoproteinemia

Drugs mentioned

• SRSD216

Snippet

Sponsor: Sirius Therapeutics Co., Ltd. | Conditions: Hyperlipoproteinemia (a) | Phase 1, Phase 2 | Status: RECRUITING